RxDoctor Payments Data

Brian Bennett, MD

Family Medicine · Freeport, ILNPI 1780657270

Payments from drug & device makers

$5,418in general payments, 2019–2025

Across 335 payments — averaging $16.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$754
  • GSK$680
  • Novo Nordisk$439
  • E.r. Squibb & Sons, L.L.C.$321
  • Amgen$321
  • Johnson & Johnson$262
  • plus $3K from 36 others

What the payments were for

  • Food & beverage$5,418100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,418 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$99,439
Medicare patients
277
Services billed
1,599

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban118$121,807
EliquisApixaban133$111,558
OzempicSemaglutide76$98,165
JardianceEmpagliflozin62$72,485
TrulicityDulaglutide36$48,365
Trelegy ElliptaFluticasone/Umeclidin/Vilanter43$40,063
Tresiba Flextouch U-100Insulin Degludec47$40,048
XifaxanRifaximin12$38,269
JanuviaSitagliptin Phosphate21$30,971
FarxigaDapagliflozin Propanediol24$25,634
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr34$20,395
Tresiba Flextouch U-200Insulin Degludec25$16,295
Breo ElliptaFluticasone/Vilanterol22$11,751
RybelsusSemaglutide12$11,442
Stiolto RespimatTiotropium Br/Olodaterol Hcl14$10,349

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$262$121,807118 claims
PfizerEliquis$754$111,558133 claims
Novo NordiskOzempic, Rybelsus$439$109,60788 claims
Boehringer IngelheimJardiance, Stiolto Respimat$230$82,83476 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$680$72,21099 claims
Lilly USA, LLCTrulicity$252$48,36536 claims
AstraZenecaFarxiga, Brilinta, Symbicort$259$38,89058 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$16$38,26912 claims
MerckJanuvia$60$30,97121 claims
Astellas Pharma US IncVeozah$110$6,49112 claims
AbbVieSynthroid$160$1,86922 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Freeport

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →